Clinical Trial Update: Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the efficacy and safety of a 7-day triple therapy for Helicobacter pylori eradication in peptic ulcer disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Snippet

Sponsor: Il-Yang Pharm. Co., Ltd. | Conditions: Peptic Ulcer | Phase 3 | Status: COMPLETED